Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist. - Burstein ES; Olsson R; Skold N; Jansen KE; Azar M; Sandiego C; Ridler K; Rabiner EA; Rhodes G; Dey PM; Pathak S (The Journal of pharmacology and experimental therapeutics, 2026)